ARK THERAPEUTICS
Live / Registered — International registration cancelled — extension of protection cancelled (as of 13 Mar 2019)
What this means for you
Registered since 26 Jan 2010. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79066961
- Registration number
- 3742666
- Mark type
- Design + words
- Filed
- 13 Mar 2009
- Published for opposition
- 10 Nov 2009
- Registered
- 26 Jan 2010
- Attorney of record
- CYNTHIA C. WEBER
Goods and services
- Class 001 — Chemicals: Diagnostic protein preparations for use in science, scientific diagnostics and industry; diagnostic preparations of genes for use in science, scientific diagnostics and industry
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; pharmaceutical preparations for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; pharmaceutical preparations to promote or suppress angiogenesis and enhance blood flow; pharmaceutical preparations for increasing the efficiency of muscle cell energy production; therapeutic agents for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; therapeutic agents for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; therapeutic agents to promote or suppress angiogenesis and enhance blood flow; therapeutic agents for increasing the efficiency of muscle cell energy production; diagnostic preparations for medical purposes; protein preparations for clinical or medical laboratory use, namely for targeting therapeutic agents to specific sites; medical dressings; surgical dressings; burn dressings; wound dressings; absorbent wound and burn dressings in the nature of pads; foot and hand dressings for medical purposes; fluid handling foot and hand dressings for medical purposes; preparations of genes for therapeutics purposes namely for the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting; preparations of genes for therapeutic purposes namely for the prevention of stenosis, namely, stenosis caused by intimal hyperplasia following surgical procedures; preparations of genes for therapeutic purposes namely to promote or suppress angiogenesis and enhance blood flow; preparations of genes for therapeutic purposes namely for increasing the efficiency of muscle cell energy production
- Class 010 — Medical apparatus: Boots and gloves for orthopaedic and medical purposes; boots and gloves for medical purposes with the ability to handle wound fluid; boots and gloves for medical use and absorbent filters, liners and inserts for use therewith; filters, soles and absorbent inserts for socks, boots and gloves for medical purposes, namely, for the treatment of wounds and burns; foot and hand dressings for medical purposes, namely, for the treatment of wounds and burns; parts and fittings for all the aforesaid goods
- Class 042 — Scientific and technological services: Scientific, medical and clinical research, all in the field of the treatment of wounds, burns, vascular and circulatory system related diseases, cancer, malignant glioma and other malignant brain tumours, macular degeneration, lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy, cachexia and muscle wasting, prevention of stenosis, increasing the efficiency of muscle cell energy production and promoting or suppressing angiogenesis and enhancing blood flow; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances; scientific, medical and clinical research in the field of gene therapy; scientific, medical and clinical research for the discovery, design, creation, development and testing in the field of pharmaceutical preparations and therapeutically active substances for use in the field of gene therapy; advisory services relating to the aforesaid services; scientific, medical and clinical research in the field of genes and genetics; medical and scientific research, namely, conducting gene therapy trials; provision of information relating to the above
Owner
Prior registrations
Prosecution history
- 11 Oct 2019 — NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
- 11 Oct 2019 — DEATH OF INTERNATIONAL REGISTRATION
- 16 Jun 2017 — TOTAL INVALIDATION PROCESSED BY THE IB
- 11 May 2017 — TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 11 May 2017 — INVALIDATION PROCESSED
- 02 May 2017 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 02 Sept 2016 — CANCELLED SECTION 71
- 07 Feb 2013 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 24 May 2010 — FINAL DISPOSITION NOTICE SENT TO IB
- 24 May 2010 — FINAL DISPOSITION PROCESSED
- 26 Apr 2010 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 26 Jan 2010 — REGISTERED-PRINCIPAL REGISTER
- 10 Nov 2009 — PUBLISHED FOR OPPOSITION
- 21 Oct 2009 — NOTICE OF PUBLICATION
- 07 Oct 2009 — LAW OFFICE PUBLICATION REVIEW COMPLETED